Search

Your search keyword '"Vaccines -- Planning"' showing total 4,607 results
Start Over Descriptor "Vaccines -- Planning"
4,607 results on '"Vaccines -- Planning"'

151. HK vaccine hub plan gathers pace with two labs to open; UN-linked infectious disease research institute will boast international and mainland scientists

Author

Wong, Olga

Subjects
World health, Medical research, Medicine, Experimental, Communicable diseases, Laboratories, Vaccines -- Planning, Scientists -- Planning, Research institutes, Company business planning, News, opinion and commentary, University of Hong Kong -- Planning, University of Cambridge -- Planning, United Nations. Development Programme -- Planning
Abstract

Top research laboratories linked to the United Nations and a British university will open in Hong Kong next year as part of the city’s ambitious plan to develop and produce [...]

Published
2023

153. Cervical cancer will be thing of the past by 2040, says NHS. DIY home kits to replace smear tests while vaccine uptake will be boosted under plans to save lives

Subjects
Do-it-yourself work -- Planning, Women -- Health aspects, Cervical cancer, Vaccines -- Planning, Company business planning, General interest
Abstract

Byline: Laura Donnelly HEALTH EDITOR CERVICAL cancer will be eliminated by 2040, saving thousands of women's lives, health chiefs are to pledge. Under the plans, the NHS could replace smear [...]

Published
2023

154. Point of Care Uncovered: Sharing knowledge and exploring media impact in the data-driven age

Author

Basch, Damon

Subjects
Acorda Therapeutics Inc. -- Planning, Biological products industry -- Planning, Vaccines -- Planning, Company business planning, Business, Health care industry
Abstract

Pharma marcomms pros are evolving their omnichannel approach and considerating how generative AI will impact the business. During this #TrendTalks roundtable, in partnership with Veradigm, panelists discussed how point-of-care advertising [...]

Published
2024

156. FDA proposes two annual COVID shots for seniors in ‘simplified’ vaccine schedule

Author

Lasek, Alicia

Subjects
United States. Food and Drug Administration -- Planning, Independent regulatory commissions, Vaccines -- Planning, Disease susceptibility, Company business planning, Business, Health, Health care industry, Seniors
Abstract

The Food and Drug Administration is proposing that each year, older adults and others at high risk of severe COVID-19 receive two shots of an updated vaccine to produce protective [...]

Published
2023

157. Clover Biopharmaceuticals updates on Covid-19 vaccine 'CpG 1018/Alum'

Subjects
Biological products industry -- Planning, Biopharmaceutics -- Planning, Vaccines -- Planning, Company business planning, Pharmaceuticals and cosmetics industries
Abstract

Clover Biopharmaceuticals Ltd, a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the globe, has provided updates on the [...]

Published
2023

158. Jordan Health leader announces retirement date

Subjects
Vaccines -- Planning, Company business planning, Business, Business, regional
Abstract

Byline: Andrea Deckert Janice Harbin, Jordan Health's president and CEO, recently announced her plans to retire at the end of 2023. Harbin became interim CEO of the Anthony L. Jordan [...]

Published
2022

159. Bangladesh plans to administer fourth COVID-19 booster shot from Dec 20

Subjects
Pfizer Inc. -- Planning, Vaccination, Vaccines -- Planning, Company business planning
Abstract

Byline: Just Earth News Dhaka: The Bangladesh government is planning to administer the fourth dose of the COVID-19 in Dhaka on Dec 20, media reports said. Initially, the shot will [...]

Published
2022

160. A second malaria vaccine

Subjects
Malaria vaccine -- Planning, Malaria, Vaccines -- Planning, Company business planning, Health
Abstract

WHO recommended a new vaccine for the prevention of malaria in children. The R21/Matrix-M vaccine is the second malaria vaccine recommended by WHO, following the RTS,S/AS01 vaccine, which received a [...]

Published
2023
Full Text
View/download PDF

161. VACCINE DIPLOMACY: The remarkable speed with which Covid-19 vaccines were created shows how quickly medical breakthroughs can take place when funds and resources are pooled. But many diseases don't receive such attention. Can Covid-19's legacy help to eliminate neglected diseases or is the system broken at its core?

Author

Rowe, Mark and Hennig, Benjamin

Subjects
Vaccination, Public health, Vaccines -- Planning, Diplomacy, Company business planning, Geography, World Health Organization -- Planning
Abstract

We've never seen anything like it. Covid-19 only emerged in December 2019, but within months, the race for a vaccine already involved 150 candidates and by November 2020, two vaccines [...]

Published
2021

162. Ocugen Inc at H.C. Wainwright BioConnect Investor Conference - Final

Subjects
Vaccines -- Planning, Company business planning, Business
Abstract

Presentation SWAYAMPAKULA RAMAKANTH, ANALYST, H.C. WAINWRIGHT & CO.: Good morning and thanks for joining us to have a conversation with Shankar Musunuri. He is the Chairman, CEO, and Co-founder of [...]

Published
2023

163. More flexible CMS vaccine mandate enforcement cheers providers

Author

Bush, Joe

Subjects
Biological products industry -- Planning, Vaccination, Vaccines -- Planning, Nursing homes -- Planning, Company business planning, Business, Health, Health care industry, Seniors
Abstract

Nursing home advocates Thursday cheered news that federal regulators are relaxing their instructions to surveyors when checking for staff compliance with a federal vaccine mandate. The Centers for Medicare & [...]

Published
2022

164. Pfizer Plans to Charge More Than $100 Per COVID-19 Shot in 2023

Subjects
Pfizer Inc. -- Planning, The Associated Press -- Planning, Health insurance industry -- Planning, News agencies -- Planning, Vaccines -- Planning, Health insurance -- Planning, Pharmaceutical industry -- Planning, Company business planning, Health
Abstract

(HealthDay News) — Some Americans could pay up to $130 to get a COVID-19 vaccine made by Pfizer starting in 2023, but most will still get it for free. A [...]

Published
2022

165. Merck, IAVI enter agreement for investigational SUDV vaccine candidate

Subjects
Merck & Company Inc. -- Planning, Vaccines -- Planning, Genetic vectors, Pharmaceutical industry -- Planning, Ebola virus, Company business planning, Business, News, opinion and commentary
Abstract

IAVI and Merck have entered into an agreement that could enable IAVI to accelerate the entry of a promising Sudan ebolavirus vaccine candidate that IAVI is developing into clinical evaluation [...]

Published
2022

166. BioNTech to establish mRNA research/manufacturing facility in Victoria

Subjects
Messenger RNA, Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

BioNTech 'announced that it has agreed a Letter of Intent with the State of Victoria in Australia on a strategic partnership between the State and BioNTech to collaborate on the [...]

Published
2022

167. The mRNA vaccine transformed Pfizer. Here's how the biopharma giant plans to retain its new 'light-speed mentality' and create drugs faster

Subjects
Pfizer Inc. -- Planning, Biological products industry -- Planning, Medical research, Medicine, Experimental, Messenger RNA, Vaccines -- Planning, Company business planning, Consumer news and advice, General interest
Abstract

(https://www.businessinsider.com/category/culture-of-innovation) Annaliesa Anderson, a leader in vaccine research, shared how the pandemic changed Pfizer. Anderson said employees embraced a 'light-speed mentality' of doing things faster and simpler. The company will [...]

Published
2022

168. How a Danish Company Grabbed Control of the Monkeypox Vaccine

Subjects
United States. National Institutes of Health -- Planning, Human monkeypox, Vaccines -- Planning, Company business planning, Consumer news and advice, General interest
Abstract

As the monkeypox outbreak appears to slow in the U.S., countries around the world are (https://www.citizen.org/article/monkeypox-vaccine-shortage/) still waiting to get access to the vaccine, called Jynneos. African countries where monkeypox [...]

Published
2022

169. Tucker Carlson Figured Out Our Plan To Destroy High Testosterone Men With Vaccine Mandates

Subjects
White supremacy movements, Vaccines -- Planning, Conspiracy, Testosterone -- Planning, Company business planning, Consumer news and advice, General interest
Abstract

Tucker Carlson has been (https://www.wonkette.com/tucker-carlson-dazzled-by-sanity-of-white-nationalist-talking-points) a fan of the white nationalist 'Great Replacement' conspiracy for some time now -- you know, the thing were we're trying to replace all of [...]

Published
2022

170. Vaxxinity initiates rolling submission for UB-612 COVID-19 vaccine with MHRA

Subjects
Independent regulatory commissions, Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Vaxxinity announced that it has initiated a rolling submission to the Medicines and Healthcare products Regulatory Agency, MHRA, in the United Kingdom for conditional marketing authorization of its UB-612 COVID-19 [...]

Published
2022

171. Vaxart price target lowered to $8 from $11 at Cantor Fitzgerald

Subjects
Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

Cantor Fitzgerald analyst Charles Duncan lowered the firm's price target on Vaxart to $8 from $11 and keeps an Overweight rating on the shares. Despite the 'encouraging' interim results from [...]

Published
2022

174. The Checkup With Dr. Wen: What's the best timing for the next covid booster?

Subjects
Vaccines -- Planning, Company business planning, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Leana S. Wen You're reading The Checkup With Dr. Wen, a newsletter on how to navigate covid-19 and other public health challenges. Click here to get the full newsletter [...]

Published
2023

175. A new, sensible plan for fall covid boosters is taking shape

Subjects
United States. Food and Drug Administration -- Planning, United States. Centers for Disease Control and Prevention -- Planning, Vaccines -- Planning, Coronaviruses, Company business planning, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Leana S. Wen As promised, U.S. health officials are devising a plan to update the booster vaccine for the fall to better protect against emerging variants of the coronavirus. [...]

Published
2023

176. Biden administration to distribute additional COVID-19 tests to schools

Subjects
United States. Department of Education -- Planning, School districts, Schools, Vaccines -- Planning, Company business planning, News, opinion and commentary, Sports and fitness
Abstract

On Wednesday, the Biden-Harris administration announced a plan to administer free COVID-19 tests to schools beginning in early December, according to a press release by the U.S. Department of Education. [...]

Published
2023

177. Major buyout firms eye Sanofi's consumer health division spinoff valued over $20 billion

Subjects
Sanofi S.A. -- Mergers, acquisitions and divestments, Vaccines -- Planning, Pharmaceutical industry -- Mergers, acquisitions and divestments, Company business planning, Company acquisition/merger, General interest, News, opinion and commentary
Abstract

Sanofi SA SNY has reportedly opened talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at more [...]

Published
2023

178. Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ(R)

Subjects
Valneva SE -- Planning, Biotechnology industry -- Planning, Travelers -- Planning, Drug approval, Vaccines -- Planning, Industrial research -- France, Research and development, Company business planning, Banking, finance and accounting industries, Business, Coalition for Epidemic Preparedness Innovations -- Planning
Abstract

Saint-Herblain (France), November 10, 2023 - https://www.globenewswire.com/Tracker?data=mYrm-rkJsumzWuRYINY-ZHWzw7GzoS5muXThkyqqEI4YT1vNFzj8AkO_rwh_x-LQkUUoxni7ZbfDBeFkrd12rQ== (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved IXCHIQ[sup.(R)], Valneva's [...]

Published
2023

179. France : Sanofi Enters Next Chapter of Play to Win Strategy

Subjects
Sanofi S.A. -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Business, international
Abstract

Sanofi provided a comprehensive update regarding its Play to Win strategy. This strategy continues to focus on the critical goals of executing transformative medicine and vaccines launches, driving agile and [...]

Published
2023

180. GET COVERED: PROTECT YOURSELF, YOUR FAMILY AND YOUR FUTURE DURING OPEN ENROLLMENT

Subjects
Medicine, Preventive, Health insurance industry -- Planning, Employee benefits, Preventive health services, Vaccines -- Planning, Health insurance -- Planning, Company business planning, Employee benefits, News, opinion and commentary
Abstract

WASHINGTON, DC -- The following information was released by the American Hospital Association (AHA): by Rick Pollack, President and CEO, AHA tools designed to assist and remind eligible people to [...]

Published
2023

181. Press Release: Sanofi Enters Next Chapter of Play to Win Strategy

Subjects
Sanofi S.A. -- Planning, Biological products industry -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Business, international
Abstract

Paris: Sanofi has issued the following press release: Sanofi today provided a comprehensive update regarding its Play to Win strategy. This strategy continues to focus on the critical goals of [...]

Published
2023

182. Philippines : Vax manufacturer, irradiation facility pitch project to NDC

Subjects
National Development Co. (Tripoli, Libya) -- Planning, Biological products industry -- Planning, Motorcycle industry -- Planning, Food processing plants, Vaccines -- Planning, Company business planning, Business, international
Abstract

The National Development Co. (NDC) said a new vaccine manufacturer and a gamma irradiation facility pitched their project proposals for possible investments. NDC General Manager Anton Mauricio told the Philippine [...]

Published
2023

183. Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs)

Subjects
Biological products industry -- Planning, Bacterial infections, Vaccines -- Planning, Company business planning, Business, international
Abstract

Basel, Switzerland: Lonza Group has issued the following press release: Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial [...]

Published
2023

184. Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad Spectrum Pneumococcal Conjugate Vaccines (PCVs)

Subjects
Biological products industry -- Planning, Bacterial infections, Vaccines -- Planning, Company business planning, General interest, News, opinion and commentary
Abstract

SAN CARLOS: Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, and Lonza, a global manufacturing partner to [...]

Published
2023

185. Health Department unveils plan to introduce new vaccines

Subjects
Vaccination, Vaccines -- Planning, Company business planning, Business, international
Abstract

In a bid to enhance the scope of available vaccines, the Department of Health is poised to incorporate new vaccines into the regular expanded immunisation programme, with an allocated budget [...]

Published
2023

186. Emergex and Saudi Arabia's Vaccine Industrial Company (VIC) have Signed MoU to Advance First-of-its-Kind Infectious Disease Solutions

Subjects
Biological products industry -- Planning, Communicable diseases, T cells, Vaccines -- Planning, Company business planning, Banking, finance and accounting industries, Business
Abstract

Emergex and VIC plan to collaborate to further develop and commercialise Emergex's proprietary T cell-based vaccine candidates as designated in Saudi Arabia and the agreed Territory (including GCC Member States, [...]

Published
2023

187. Australia : Innovative pharmacy pilot to be expanded statewide

Subjects
Health care reform, Pharmacy -- Planning, Vaccines -- Planning, Company business planning, Business, international
Abstract

The Queensland Government is continuing to take innovative steps to improve Queenslanders access to healthcare close to home. A pilot enabling pharmacists to administer a wider range of vaccines and [...]

Published
2023

188. Injectable Facility in Hyderabad

Subjects
Biological products industry -- International economic relations, Vaccines -- Planning, Company business planning, Business, international
Abstract

Scope : To Set up Injectable Facility in Hyderabad, Telangana One of the leading vaccine manufacturers in the country, Bharat Serums and Vaccines Limited (BSV) is planning to set up [...]

Published
2023

189. Bharat Serums breaks ground for pharmaceutical unit in Hyderabad

Subjects
Biological products industry -- International economic relations, Vaccines -- Planning, Company business planning, Business, international
Abstract

Biotech firm Bharat Serums and Vaccines (BSV) laid the ground-breaking ceremory for its new bio-pharmaceutical manufacturing plant in the presence of Industries and IT Minister KT Rama Rao on 21 [...]

Published
2023

190. Australia : New Milestone For Moderna Vaccine Facility

Subjects
RNA, Vaccines -- Planning, Company business planning, Business, international
Abstract

Thanks to the Andrews Labor Government, Victorians are one step closer to locally manufactured mRNA vaccines and medicines, with construction of Modernas mRNA vaccine manufacturing facility reaching the halfway mark, [...]

Published
2023

191. THE AMERICAN COLLEGE OF PREVENTIVE MEDICINE HOSTS PHYSICIAN RALLY FOR 'BACK TO SCHOOL'

Subjects
Vaccination, Physicians -- Planning, Vaccines -- Planning, Company business planning, News, opinion and commentary
Abstract

WASHINGTON, DC -- The following information was released by the American College of Preventive Medicine (ACPM): As COVID-19 vaccines roll out across the country, preventive medicine physicians are vital to [...]

Published
2023

192. Philippines : Speaker sees affordable chicken meat, egg prices with PBBMs initiative to acquire avian flu vaccine

Subjects
Meat industry -- Mergers, acquisitions and divestments, Poultry industry -- Mergers, acquisitions and divestments, Vaccines -- Planning, Company business planning, Company acquisition/merger, Business, international
Abstract

Speaker Ferdinand Martin G. Romualdez today lauded the initiative of President Ferdinand R. Marcos, Jr. to hasten the acquisition of avian flu vaccines would help revitalize the countrys poultry industry [...]

Published
2023

193. Marcos secures $22M in investment pledges from Indonesian companies

Subjects
Pasifik Satelit Nusantara -- International economic relations, Biological products industry -- International economic relations, Telecommunications services industry -- International economic relations, Health care industry -- International economic relations, Vaccines -- Planning, Communications industry -- International economic relations, Health care industry, Company business planning, Telecommunications services industry, Banking, finance and accounting industries
Abstract

PHILIPPINE President Ferdinand R. Marcos, Jr. secured $22 million (P1.3 billion) in investment pledges from Indonesian companies in the animal health, artificial intelligence (AI) and digital sectors, according to the [...]

Published
2023

194. Vaccine Transportation Services

Subjects
Vaccines -- Planning, Company business planning, Business, international
Abstract

Contract notice: vaccine transportation services The procuring organization plans to purchase vaccine transportation services. requirements for the object of procurement are set out in appendix 2 of the special procurement [...]

Published
2023

195. Navigating What Comes Next for mRNA Therapeutics

Author

Patterson, Dale

Subjects
Raw materials -- Planning, Messenger RNA, Vaccines -- Planning, Company business planning
Abstract

https://medcitynews.com/2023/12/navigating-what-comes-next-for-mrna-therapeutics/ The next era for mRNA-based therapeutics and vaccines is here, and it’s time to move from an R&D mindset to a focus on long-term success with mRNA and bringing [...]

Published
2023

196. Opening Up? Higher ed institutions plan to bring more students back to campus as COVID-19 vaccines roll out

Author

Arnett, Autumn A.

Subjects
Pfizer Inc. -- Planning, Students -- Planning, Executives -- Planning, Vaccines -- Planning, Company business planning, Education, Ethnic, cultural, racial issues/studies
Abstract

As the Pfizer vaccine for COVID-19 begins to roll out to states, many in the higher ed sector and beyond are beginning to look forward to some sense of normalcy. [...]

Published
2021

197. New COVID booster shot rollout expected near Labor Day: officials

Author

Lasek, Alicia

Subjects
Vaccines -- Planning, Nursing homes -- Planning, Company business planning, Business, Health, Health care industry, Seniors
Abstract

The Food and Drug Administration expects to authorize new, variant-targeting COVID-19 booster shots shortly after Labor Day. The White House plans to distribute the vaccines as part of a fall [...]

Published
2022

198. Biden Administration May Stop Buying COVID-19 Vaccines, Treatments by Fall

Subjects
Vaccines -- Planning, Company business planning, Health
Abstract

HealthDay News — The Biden administration plans to stop buying COVID-19 tests, vaccines, and treatments as early as the fall, White House COVID-19 Response Coordinator Ashish Jha, MD, said Tuesday. [...]

Published
2022

199. Reformulated Booster Shots Ready by September, White House Says

Subjects
Pfizer Inc. -- Planning, Biological products industry -- Planning, Vaccines -- Planning, Pharmaceutical industry -- Planning, Company business planning, Health
Abstract

(HealthDay News) — Americans could be getting updated COVID-19 booster shots that can battle the newest omicron variants as soon as mid-September. People close to deliberations say that the Biden [...]

Published
2022

200. Biden to declare monkeypox public health emergency, Washington Post says

Subjects
Human monkeypox, Biological products industry -- Planning, Public health, Vaccines -- Planning, Company business planning, Business, News, opinion and commentary
Abstract

The Biden administration plans to declare the monkeypox outbreak a public health emergency as soon as today, Dan Diamond of Washington Post reports. The declaration would come from Health and [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results